LS Investment Advisors LLC cut its holdings in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 3.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,279 shares of the medical instruments supplier’s stock after selling 142 shares during the period. LS Investment Advisors LLC’s holdings in West Pharmaceutical Services were worth $472,000 as of its most recent SEC filing.
Several other large investors have also bought and sold shares of WST. Dimensional Fund Advisors LP grew its stake in West Pharmaceutical Services by 2.3% in the third quarter. Dimensional Fund Advisors LP now owns 349,346 shares of the medical instruments supplier’s stock worth $43,132,000 after purchasing an additional 7,877 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of West Pharmaceutical Services during the 3rd quarter valued at $520,000. Mackenzie Financial Corp purchased a new stake in shares of West Pharmaceutical Services during the 3rd quarter valued at $275,000. AQR Capital Management LLC lifted its holdings in shares of West Pharmaceutical Services by 146.1% during the 3rd quarter. AQR Capital Management LLC now owns 27,376 shares of the medical instruments supplier’s stock valued at $3,381,000 after purchasing an additional 16,251 shares during the last quarter. Finally, Teachers Advisors LLC lifted its holdings in shares of West Pharmaceutical Services by 5.1% during the 3rd quarter. Teachers Advisors LLC now owns 92,491 shares of the medical instruments supplier’s stock valued at $11,420,000 after purchasing an additional 4,496 shares during the last quarter. Hedge funds and other institutional investors own 92.56% of the company’s stock.
WST has been the subject of several analyst reports. Zacks Investment Research lowered West Pharmaceutical Services from a “hold” rating to a “sell” rating in a report on Friday, April 19th. William Blair initiated coverage on West Pharmaceutical Services in a report on Tuesday, April 23rd. They set an “outperform” rating and a $112.16 price objective for the company. Finally, Jefferies Financial Group lowered West Pharmaceutical Services from a “buy” rating to a “hold” rating and set a $122.00 price objective for the company. in a report on Wednesday, May 1st.
In other news, VP Daniel Malone sold 4,458 shares of the firm’s stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $123.03, for a total transaction of $548,467.74. Following the sale, the vice president now directly owns 33,478 shares in the company, valued at approximately $4,118,798.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.70% of the stock is owned by company insiders.
WST traded up $0.23 during midday trading on Friday, hitting $116.29. 154,100 shares of the company were exchanged, compared to its average volume of 416,035. The company has a market capitalization of $8.53 billion, a P/E ratio of 41.38, a P/E/G ratio of 3.61 and a beta of 1.29. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.13 and a current ratio of 2.88. West Pharmaceutical Services Inc. has a 1-year low of $90.63 and a 1-year high of $125.09.
West Pharmaceutical Services (NYSE:WST) last posted its earnings results on Thursday, April 25th. The medical instruments supplier reported $0.74 EPS for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.08. West Pharmaceutical Services had a return on equity of 16.38% and a net margin of 12.53%. The firm had revenue of $443.50 million for the quarter, compared to analysts’ expectations of $431.00 million. During the same period last year, the firm earned $0.62 EPS. The company’s quarterly revenue was up 6.7% on a year-over-year basis. Analysts forecast that West Pharmaceutical Services Inc. will post 2.87 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 7th. Stockholders of record on Wednesday, July 24th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date of this dividend is Tuesday, July 23rd. West Pharmaceutical Services’s dividend payout ratio (DPR) is presently 21.35%.
WARNING: “LS Investment Advisors LLC Has $472,000 Stake in West Pharmaceutical Services Inc. (WST)” was first published by Sundance Herald and is the property of of Sundance Herald. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://sundanceherald.com/2019/05/24/ls-investment-advisors-llc-sells-142-shares-of-west-pharmaceutical-services-inc-wst.html.
West Pharmaceutical Services Company Profile
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.
Recommended Story: What is a trade deficit?
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.